Pure Global AI
Manufacturer profile

FUJIREBIO EUROPE N.V.

TaiwanBelgium18 products registeredMar 13, 2015 – Oct 29, 2020
VerifiedTFDA · Taiwan Food and Drug Administration registry
18
Total products
18
Product types
0
Active products
Oct 2020
Latest registration
Company details
Address
TECHNOLOGIEPARK 6 B-9052 GENT, BELGIUM
Regulatory footprint
Search FUJIREBIO EUROPE N.V. across other regulatory registries
Recent registrations
Latest 5 products registered by this manufacturer
Most popular products
Products with most registrations
Authorized representatives
Taiwan authorized representatives for this manufacturer
Recent registered products
Most recent products (showing top 20)
Inno-Lia infectious disease analysis software
Registered: Oct 29, 2020 • Expires: Oct 29, 2025
Cancelled
Risk Class
Class 2
AR
Taiwan Fu Pharmaceutical Co., Ltd
INNO-LIA Syphilis Score
Registered: Apr 17, 2020 • Expires: Apr 17, 2025
Cancelled
Risk Class
Class 2
Type
MD
AR
Taiwan Fu Pharmaceutical Co., Ltd
INNO-LIA HIV I/II Score
Registered: Feb 06, 2020 • Expires: Feb 06, 2025
Cancelled
Risk Class
Class 3
Type
MD
AR
Taiwan Fu Pharmaceutical Co., Ltd
INNO-LIA HTLV I/II Score
Registered: Feb 04, 2020 • Expires: Feb 04, 2025
Cancelled
Risk Class
Class 3
Type
MD
AR
Taiwan Fu Pharmaceutical Co., Ltd
INNO-LIA HCV Score
Registered: Jan 09, 2020 • Expires: Jan 09, 2025
Cancelled
Risk Class
Class 3
Type
MD
AR
Taiwan Fu Pharmaceutical Co., Ltd
LiRAS for LiPA HLA
Registered: May 13, 2016 • Expires: May 13, 2026
Cancelled
Risk Class
Class 2
Type
MD
AR
Taiwan Fu Pharmaceutical Co., Ltd
INNO-LiPA HLA-DRB decorder Amplification
Registered: Jul 28, 2015 • Expires: Jul 28, 2025
Cancelled
Risk Class
Class 2
Type
MD
AR
Taiwan Fu Pharmaceutical Co., Ltd
INNO-LiPA HLA-DRB1 Amplification Plus
Registered: Jul 23, 2015 • Expires: Jul 23, 2025
Cancelled
Risk Class
Class 2
Type
MD
AR
Taiwan Fu Pharmaceutical Co., Ltd
INNO-LiPA HLA-DQB1 Update
Registered: Jul 23, 2015 • Expires: Jul 23, 2025
Cancelled
Risk Class
Class 2
Type
MD
AR
Taiwan Fu Pharmaceutical Co., Ltd
INNO-LiPA HLA-DQB1 MultiPlex
Registered: Jul 23, 2015 • Expires: Jul 23, 2025
Cancelled
Risk Class
Class 2
Type
MD
AR
Taiwan Fu Pharmaceutical Co., Ltd
INNO-LiPA HLA-DRB1 Plus
Registered: Jul 21, 2015 • Expires: Jul 21, 2025
Cancelled
Risk Class
Class 2
Type
MD
AR
Taiwan Fu Pharmaceutical Co., Ltd
INNO-LiPA HLA-DRB decoder
Registered: Jul 16, 2015 • Expires: Jul 16, 2025
Cancelled
Risk Class
Class 2
Type
MD
AR
Taiwan Fu Pharmaceutical Co., Ltd
INNO-LiPA HLA-A MultiPlex
Registered: Jun 30, 2015 • Expires: Jun 30, 2025
Cancelled
Risk Class
Class 2
Type
MD
AR
Taiwan Fu Pharmaceutical Co., Ltd
INNO-LiPA HLA-C Line Probe Assay
Registered: Jun 18, 2015 • Expires: Jun 18, 2025
Cancelled
Risk Class
Class 2
Type
MD
AR
Taiwan Fu Pharmaceutical Co., Ltd
INNO-LiPA HLA-C Amplification
Registered: Apr 22, 2015 • Expires: Apr 22, 2025
Cancelled
Risk Class
Class 2
Type
MD
AR
Taiwan Fu Pharmaceutical Co., Ltd
INNO-LiPA HLA-B Multiplex Plus 100
Registered: Apr 21, 2015 • Expires: Apr 21, 2025
Cancelled
Risk Class
Class 2
Type
MD
AR
Taiwan Fu Pharmaceutical Co., Ltd
INNO-LiPA HLA-B Update Plus 100
Registered: Apr 21, 2015 • Expires: Apr 21, 2025
Cancelled
Risk Class
Class 2
Type
MD
AR
Taiwan Fu Pharmaceutical Co., Ltd
INNO-LiPA HLA-A Update 100
Registered: Mar 13, 2015 • Expires: Mar 13, 2025
Cancelled
Risk Class
Class 2
Type
MD
AR
Taiwan Fu Pharmaceutical Co., Ltd
About this profile

Explore comprehensive manufacturer profile for FUJIREBIO EUROPE N.V. based in Belgium through Pure Global AI's free Taiwan medical device database. This manufacturer has 18 products registered in Taiwan across 18 unique product categories. Their regulatory history spans from Mar 13, 2015 to Oct 29, 2020.

This page provides detailed insights including 5 recent product registrations, 5 most popular products with Inno-Lia infectious disease analysis software having 1 registrations, and 1 authorized representatives including Taiwan Fu Pharmaceutical Co., Ltd. Pure Global AI offers free access to Taiwan's medical device database, enabling global MedTech companies to analyze market dynamics and identify opportunities.